---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-018632"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2022-07-06T23:59:59+00:00"
generated_at: "2026-06-24T20:30:07.261208+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nephros prelim Q2 revenue $2.9M, up 27% YoY; expects positive net cash flow in 12 months

## Summary
- Q2 2022 preliminary net revenue ~$2.9M, a 27% increase from $2.3M in Q2 2021.
- Active customer sites grew 21% YoY to 1,349, adding 232 sites in trailing 12 months.
- Expense management plan includes headcount reductions and facility consolidations; company projects positive net cash flow within 12 months.
- Ended Q2 with approximately $4.2M in cash on a consolidated basis.

## SEC filing metadata
- accession: 0001493152-22-018632
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2022-07-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/0001493152-22-018632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315222018632/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-018632
- JSON: https://secwatch.observer/filing/0001493152-22-018632.json
- Plain text: https://secwatch.observer/filing/0001493152-22-018632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.